Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology...
products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
Next
(114)
•••
Majictrader
X
View Profile
View Bullboard History
Comment by
Majictrader
on Jan 06, 2021 10:35pm
RE:RE:RE:RE:RE:Innovate Buy Out?
I guess...all this doesnt matter...we need a deal...we need settlement in our favour...anything that makes money for us ;). Better before this bull run ends.
(1020)
•••
Maxmoe
X
View Profile
View Bullboard History
Comment by
Maxmoe
on Jan 06, 2021 8:36pm
RE:RE:RE:RE:Innovate Buy Out?
This has nothing to do with innovotech's business and even less to do with cph from my reading. Alan savage is a director of innovotech. He exchanged his personal holdings of cph shares for
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(5)
•••
PitchinPennies
X
View Profile
View Bullboard History
Comment by
PitchinPennies
on Jan 06, 2021 3:27pm
RE:RE:RE:Innovate Buy Out?
Interesting to think that a venture-board titmouse such as Innovotech might try to catch and eat a one-time lion of the TSX, now that the lion is old, sick and confused. It seems far-fetched, but
...more
(114)
•••
Majictrader
X
View Profile
View Bullboard History
Comment by
Majictrader
on Jan 06, 2021 1:14pm
RE:RE:Innovate Buy Out?
I guess they are looking for value buys and possible take over candidates. Nexgenrx has been stuck there for a long time. So has been Cipher.
(5)
•••
PitchinPennies
X
View Profile
View Bullboard History
Comment by
PitchinPennies
on Jan 06, 2021 11:58am
RE:RE:RE:Innovate Buy Out?
Reverse takeover of a distressed operation that may still have some legacy value? Innovotech graduates to the TSX main board, chucks all the doddering Mulls and brings some normalcy to operations
...more
(1020)
•••
Maxmoe
X
View Profile
View Bullboard History
Comment by
Maxmoe
on Jan 06, 2021 9:38am
RE:RE:Innovate Buy Out?
Very strange transaction. Beats me why the board of innovate would allow one of its directors pull this off. Who is that guy , trump? Instead of selling his shares in cph in the market and using the
...more
(28)
•••
pabaloo
X
View Profile
View Bullboard History
Comment by
pabaloo
on Jan 05, 2021 8:30pm
RE:Innovate Buy Out?
Really weird a penny company buying shares in Cipher? Couldn't even find a affiliation wonder why there spending money on us?
(28)
•••
pabaloo
X
View Profile
View Bullboard History
Post by
pabaloo
on Jan 05, 2021 8:11pm
Innovate Buy Out?
Innovotech acquires shares of NexgenRX, Cipher Pharma 2021-01-05 10:10 ET - News Release See News Release (C-IOT) Innovotech Inc Mr. James Timourian reports
...more
(28)
•••
pabaloo
X
View Profile
View Bullboard History
Comment by
pabaloo
on Jan 05, 2021 7:12pm
RE:RE:RE:RE:RE:RE:Takeover talks with Bausch Health?
Totally agree Craig has no interest in giving away the company at a discount. Good for him Bausch can suck his big toe if they think there garbage gets them an easy deal. Trulance is worth 25 million
...more
(5)
•••
PitchinPennies
X
View Profile
View Bullboard History
Comment by
PitchinPennies
on Jan 05, 2021 5:22pm
RE:RE:RE:RE:RE:Takeover talks with Bausch Health?
Either HLS (HLS.TO, $533M mkt cap) or Knight (GUD.TO, $700M mkt cap) could easily swallow Cipher at the current level. Neither would really need the tax loss. Neither would ever pay a premium. I
...more
(28)
•••
pabaloo
X
View Profile
View Bullboard History
Comment by
pabaloo
on Jan 05, 2021 1:26pm
RE:First Generic Drug Approvals 1n 2020
Teva/Activis already has first launch and exclusive rights to Absorica for 9 months or the end of September and it looks like they will not exercise it. Good news for Cipher and Sun. Now we wait for
...more
(1020)
•••
Maxmoe
X
View Profile
View Bullboard History
Comment by
Maxmoe
on Jan 04, 2021 10:47pm
RE:RE:RE:RE:Takeover talks with Bausch Health?
There are privates. Apparently apotex is not the only private drug co in Canada. It's so huge the tax losses probably don't matter and without Barry that company doesn't know what's up
...more
(27)
•••
mingzhu
X
View Profile
View Bullboard History
Post by
mingzhu
on Jan 04, 2021 10:02pm
First Generic Drug Approvals 1n 2020
https://www.fda.gov/drugs/drug-and-biologic-approval-and-ind-activity-reports/first-generic-drug-approvals
(28)
•••
pabaloo
X
View Profile
View Bullboard History
Comment by
pabaloo
on Jan 04, 2021 7:52pm
RE:RE:RE:RE:Takeover talks with Bausch Health?
With Activis/Teva failure to launch a generic Absorica makes a valuation really tough. Cipher can expect a 2 million Winfall with each month that passes by and it also gets Sun time to switch all new
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >